Apoptosis in multiple sclerosis - etiopathogenetic relevance and perspectives for new therapeutic strategies

被引:0
|
作者
Aktas, O [1 ]
Wendling, U [1 ]
Zschenderlein, R [1 ]
Zipp, F [1 ]
机构
[1] Humboldt Univ, Fak Med, Neurol Klin & Poliklin, D-1040 Berlin, Germany
来源
NERVENARZT | 2000年 / 71卷 / 10期
关键词
multiple sclerosis; apoptosis; immunopathogenesis; CD95; TNF;
D O I
10.1007/s001150050664
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Apoptosis, or programmed cell death, is a physiological cell suicide program mainly leading to selective elimination of useless cells. This mechanism is important for the homeostasis of the immune system and presumably plays a two-sided role in the pathogenesis of multiple sclerosis (MS). On the one hand, evidence has been provided that impaired apoptosis might result in increased numbers or persistence of activated myelin-specifier cells, thus inducing the pathophysiologic processes in MS. On the other hand, local tissue damage might involve apoptosis of glial and neuronal cells and lead to the clinical symptoms. Here, an overview is presented on the current knowledge of the role of apoptosis in the pathogenesis of MS, and implications for related therapeutic strategies are discussed.
引用
收藏
页码:767 / 773
页数:9
相关论文
共 50 条
  • [41] Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
    Faissner, Simon
    Plemel, Jason R.
    Gold, Ralf
    Yong, V. Wee
    NATURE REVIEWS DRUG DISCOVERY, 2019, 18 (12) : 905 - 922
  • [42] Novel therapeutic strategies for multiple sclerosis-an overview
    Aktas, O.
    Hartung, H. -P.
    NERVENHEILKUNDE, 2010, 29 (05) : 267 - 272
  • [43] Neuroglial components of brain lesions may provide new therapeutic strategies for multiple sclerosis
    Akram Mokhtarzadeh Khanghahi
    Atefeh Rayatpour
    Hossein Baharvand
    Mohammad Javan
    Neurological Sciences, 2023, 44 : 3795 - 3807
  • [44] Multiple sclerosis patients' cerebrospinal fluid offers new clues for potential therapeutic strategies
    Genetic Engineering and Biotechnology News, 2019, 39 (08): : 11
  • [45] Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis and their application for new therapeutic strategies
    Martin, R
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 1997, (49): : 53 - 67
  • [46] Neuroglial components of brain lesions may provide new therapeutic strategies for multiple sclerosis
    Khanghahi, Akram Mokhtarzadeh
    Rayatpour, Atefeh
    Baharvand, Hossein
    Javan, Mohammad
    NEUROLOGICAL SCIENCES, 2023, 44 (11) : 3795 - 3807
  • [47] New therapeutic strategies in the management of systemic sclerosis
    Allanore, Yannick
    Avouac, Jerome
    Wipff, Julien
    Kahan, Andre
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (05) : 607 - 615
  • [48] Therapeutic perspectives and strategies for obtaining new NSAIDs
    Rodríguez, SC
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2000, 22 (06): : 363 - 364
  • [49] PHOTORECEPTOR DEGENERATION: THERAPEUTIC STRATEGIES AND NEW PERSPECTIVES
    Fradot, Mathias
    Yang, Ying
    Rosolen, Serge
    Sahel, Jose
    Picaud, Serge
    BULLETIN DE L ACADEMIE VETERINAIRE DE FRANCE, 2011, 164 (01): : 57 - 65
  • [50] Quality of life in multiple sclerosis.: Measures, relevance, problems, and perspectives
    Pöllman, W
    Busch, C
    Voltz, R
    NERVENARZT, 2005, 76 (02): : 154 - 169